Bank of America
CDIO icon

Bank of America’s Cardio Diagnostics CDIO Stock Holding History

Bank of America’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16
Closed -$43 – 5900
2025
Q4 		$43 Buy
16
+1
+7% +$4 ﹤0.01% 6982
2025
Q3 		$60 Hold
15
– – ﹤0.01% 7964
2025
Q2 		$54 Buy
15
+5
+50% +$37 ﹤0.01% 8084
2025
Q1 		$103 Hold
10
– – ﹤0.01% 7823
2024
Q4 		$272 Buy
10
+5
+100% +$69 ﹤0.01% 7527
2024
Q3 		$36 Hold
5
– – ﹤0.01% 7880
2024
Q2 		$83 Buy
+5
New +$118 ﹤0.01% 7742
2023
Q2 		– Sell
-500
Closed -$58.6K – 7723
2023
Q1 		$58.6K Buy
+500
New +$39.4K ﹤0.01% 6450
2022
Q4 		– Sell
-7,500
Closed -$2.26M – 8230
2022
Q3 		$2.26M Hold
7,500
– – ﹤0.01% 4161
2022
Q2 		$2.24M Hold
7,500
– – ﹤0.01% 4211
2022
Q1 		$2.23M Buy
+7,500
New +$2.22M ﹤0.01% 4475

Other funds holding CDIO

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America's CDIO Position: Q1 2026 in Review

Bank of America sold out of Cardio Diagnostics (CDIO) in Q1 2026, closing a stake of 16 shares — an estimated $43 sold.

Bank of America first reported a position in CDIO in Q1 2022 and held it in 11 quarters. The position peaked at $2.26M in Q3 2022. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

  • Bank of America reported no remaining Cardio Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 16 Cardio Diagnostics shares in Q1 2026, an estimated $43.
  • Bank of America first reported a position in Cardio Diagnostics in Q1 2022 and held it in 11 quarters.
  • Bank of America's Cardio Diagnostics position peaked at $2.26M in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.